Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Stackinstockson Dec 08, 2017 1:05pm

18 Views

Post# 27118809

RE:RE:RE:STACKINSTOCKS

hahaha I was invested in this and sold the other day after being fed up with the ridiculously poorly executed strategy and lack of any promised results

You guys are hilarious, so paranoid about the big bad bashers. Great input though saying this could get to .20 cents, top notch information. You must be quite the investor.

Bullboard Posts

Rising miner increases graphite price, restarts Québec mill